Shenouda Maged Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$312,649.11
Insider Sells Quantity
14
Insider Sells Sum
$1.26M

Insider Activity of Shenouda Maged

According to the SEC Form 4 filings, Shenouda Maged, being in a position of

  1. Chief Financial Officer at Relmada Therapeutics, Inc.,
    оver the last 12 months, has bought 711665 shares for $1.99M, and sold 0 shares,
    over all time since 2015-12-14, has bought 1003750 shares for $2.4M, and sold 36000 shares for $1.26M.

Biography of Shenouda Maged

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $1,992,0504100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-09-10PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
79,800
0.0794%
$4.25$339,150-12.9%
2026-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
120,200
0.1177%
$4.20$504,840-12.47%
2025-12-15PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
11,665
0.015%
$4.12$48,060+9.75%
2025-11-05PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
500,000
1.4664%
$2.20$1.1M+81.27%
2025-05-20PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
60,000
0.1586%
$0.52$31,422+523.12%
2025-05-19PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
90,000
0.2586%
$0.49$43,686+617.09%
2025-05-16PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
50,000
0.1444%
$0.44$22,100+685.25%
2024-09-11PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
24,120
0.0839%
$2.95$71,154-19.99%
2024-09-10PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
21,118
0.068%
$2.73$57,652-14.01%
2024-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
8,194
0.0248%
$2.55$20,895-13.39%
2024-01-31PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
6,875
0.0235%
$4.06$27,943-15.27%
2024-01-30PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
15,000
0.0491%
$3.89$58,323-16.08%
2024-01-29PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
10,800
0.035%
$3.65$39,450-9.95%
2021-03-10SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,373
0.0144%
$35.11$83,313-27.12%
2021-03-09SaleRelmada Therapeutics, Inc.
RLMD
CFO
7,527
0.0464%
$35.56$267,693-27.01%
2021-03-08SaleRelmada Therapeutics, Inc.
RLMD
CFO
100
0.0006%
$35.00$3,500-26.23%
2021-02-24SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,000
0.018%
$34.18$102,529-25%
2021-02-11SaleRelmada Therapeutics, Inc.
RLMD
CFO
1,428
0.0085%
$35.39$50,542-27.32%
2021-02-10SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,410
0.0146%
$35.20$84,825-24.75%
2021-02-09SaleRelmada Therapeutics, Inc.
RLMD
CFO
5,359
0.0326%
$35.24$188,843-24.86%
Total: 30
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.